Works matching IS 09697128 AND DT 2013 AND VI 20 AND IP 9

Results: 10

Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 875, doi. 10.1038/gt.2013.9

By:

Nemunaitis, J;
Senzer, N;
Olivares, J;
Kumar, P;
Barve, M;
Kuhn, J;
Nemunaitis, T;
Magee, M;
Yu, Y;
Wallraven, G;
Pappen, B O;
Maples, P B

Publication type:

Article

Sequential, timely and controlled expression of hVEGF<sub>165</sub> and Ang-1 effectively improves functional angiogenesis and cardiac function in vivo.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 893, doi. 10.1038/gt.2013.12

By:

Zhang, H;
Yuan, Y L;
Wang, Z;
Jiang, B;
Zhang, C S;
Wang, Q;
Xu, X H;
Dong, H Y;
Zhang, Z M

Publication type:

Article

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 958, doi. 10.1038/gt.2013.25

By:

Arber, C;
Abhyankar, H;
Heslop, H E;
Brenner, M K;
Liu, H;
Dotti, G;
Savoldo, B

Publication type:

Article

Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 913, doi. 10.1038/gt.2013.14

By:

Heldermon, C D;
Qin, E Y;
Ohlemiller, K K;
Herzog, E D;
Brown, J R;
Vogler, C;
Hou, W;
Orrock, J L;
Crawford, B E;
Sands, M S

Publication type:

Article

Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 901, doi. 10.1038/gt.2013.13

By:

Lompré, A-M;
Hadri, L;
Merlet, E;
Keuylian, Z;
Mougenot, N;
Karakikes, I;
Chen, J;
Atassi, F;
Marchand, A;
Blaise, R;
Limon, I;
McPhee, S W J;
Samulski, R J;
Hajjar, R J;
Lipskaia, L

Publication type:

Article

Percutaneous gene therapy heals cranial defects.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 922, doi. 10.1038/gt.2013.15

By:

Layliev, J;
Sagebin, F;
Weinstein, A;
Marchac, A;
Szpalski, C;
Saadeh, P B;
Warren, S M

Publication type:

Article

Local sustained delivery of oncolytic adenovirus with injectable alginate gel for cancer virotherapy.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 880, doi. 10.1038/gt.2013.10

By:

Choi, J-W;
Kang, E;
Kwon, O-J;
Yun, T J;
Park, H-K;
Kim, P-H;
Kim, S W;
Kim, J H;
Yun, C-O

Publication type:

Article

Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 939, doi. 10.1038/gt.2013.17

By:

Igoucheva, O;
Grazzini, M;
Pidich, A;
Kemp, D M;
Larijani, M;
Farber, M;
Lorton, J;
Rodeck, U;
Alexeev, V

Publication type:

Article

Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 949, doi. 10.1038/gt.2013.18

By:

Cavazza, A;
Cocchiarella, F;
Bartholomae, C;
Schmidt, M;
Pincelli, C;
Larcher, F;
Mavilio, F

Publication type:

Article

Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.

Published in:

Gene Therapy, 2013, v. 20, n. 9, p. 930, doi. 10.1038/gt.2013.16

By:

Katwal, A B;
Konkalmatt, P R;
Piras, B A;
Hazarika, S;
Li, S S;
John Lye, R;
Sanders, J M;
Ferrante, E A;
Yan, Z;
Annex, B H;
French, B A

Publication type:

Article